TREM-1 has been investigated as a biomarker and therapeutic target in both infectious diseases, such as pneumonia or sepsis8, and non-infectious inflammatory diseases, such as atherosclerosis6, Behçet ́s disease (BD)9 or rheumatoid arthritis (RA)6,10. This evidence concerns the gene TREM1 and rheumatoid arthritis.